Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

YIM Oral Poster

Poster

1204 - EGR2 Hotspot Mutations Drive BTKi Resistance in Chronic Lymphocytic Leukemia via CD27-CD70 Interaction-Mediated T-Cell Exhaustion

    Primary Author(s)

  • Huayuan Zhu, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

    • Co-Author / Presenter(s)

  • DY

    Dan Yang, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

    • Co-Author(s)

  • XL

    Xiao Lu, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • Yeqin Sha, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • LD

    Luomengjia Dai, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • ZZ

    Ziyuan Zhou, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • YM

    Yi Miao, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • Yi Xia, MD

    Attending Physician, Department of Hematology
    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • HJ

    Hui Jin, MD

    Research fellow
    the First Affiliated Hospital with Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • JL

    Jianyong Li, MD

    Chief of Hematology department
    Department of Hematology, Key Laboratory of Nanjing Medical University, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China
    Nanjing, Jiangsu, China (People's Republic)